Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS
- PMID: 22463693
- PMCID: PMC3965773
- DOI: 10.1111/j.1601-183X.2012.00779.x
Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS
Abstract
Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder associated with premutation alleles of the fragile X mental retardation 1 (FMR1) gene. Approximately 40% of older male premutation carriers, and a smaller proportion of females, are affected by FXTAS; due to the lower penetrance the characterization of the disorder in females is much less detailed. Core clinical features of FXTAS include intention tremor, cerebellar gait ataxia and frequently parkinsonism, autonomic dysfunction and cognitive deficits progressing to dementia in up to 50% of males. In this study, we report the clinical, molecular and neuropathological findings of eight female premutation carriers. Significantly, four of these women had dementia; of the four, three had FXTAS plus dementia. Post-mortem examination showed the presence of intranuclear inclusions in all eight cases, which included one asymptomatic premutation carrier who died from cancer. Among the four subjects with dementia, three had sufficient number of cortical amyloid plaques and neurofibrillary tangles to make Alzheimer's disease a highly likely cause of dementia and a fourth case had dementia with cortical Lewy bodies. Dementia appears to be more common than originally reported in females with FXTAS. Although further studies are required, our observation suggests that in a portion of FXTAS cases there is Alzheimer pathology and perhaps a synergistic effect on the progression of the disease may occur.
© 2012 The Authors. Genes, Brain and Behavior © 2012 Blackwell Publishing Ltd and International Behavioural and Neural Genetics Society.
Figures

Similar articles
-
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS).Brain. 2006 Jan;129(Pt 1):243-55. doi: 10.1093/brain/awh683. Epub 2005 Dec 5. Brain. 2006. PMID: 16332642
-
FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS).RNA Biol. 2004 Jul;1(2):103-5. doi: 10.4161/rna.1.2.1035. Epub 2004 Jul 17. RNA Biol. 2004. PMID: 17179750
-
Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles.JAMA Neurol. 2013 Aug;70(8):1022-9. doi: 10.1001/jamaneurol.2013.2934. JAMA Neurol. 2013. PMID: 23753897 Free PMC article.
-
Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications.Int J Mol Sci. 2020 Jun 20;21(12):4391. doi: 10.3390/ijms21124391. Int J Mol Sci. 2020. PMID: 32575683 Free PMC article. Review.
-
Fragile X-associated tremor/ataxia syndrome (FXTAS).Ment Retard Dev Disabil Res Rev. 2004;10(1):25-30. doi: 10.1002/mrdd.20005. Ment Retard Dev Disabil Res Rev. 2004. PMID: 14994285 Review.
Cited by
-
Emerging topics in FXTAS.J Neurodev Disord. 2014;6(1):31. doi: 10.1186/1866-1955-6-31. Epub 2014 Jul 30. J Neurodev Disord. 2014. PMID: 25642984 Free PMC article. Review.
-
Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor/Ataxia Syndrome.Cerebellum. 2022 Feb;21(1):86-98. doi: 10.1007/s12311-021-01262-7. Epub 2021 May 27. Cerebellum. 2022. PMID: 34046842
-
Risk Factors for Cognitive Impairment in Fragile X-Associated Tremor/Ataxia Syndrome.J Geriatr Psychiatry Neurol. 2016 Nov;29(6):328-337. doi: 10.1177/0891988716666379. Epub 2016 Sep 21. J Geriatr Psychiatry Neurol. 2016. PMID: 27647792 Free PMC article.
-
Newborn screening and cascade testing for FMR1 mutations.Am J Med Genet A. 2013 Jan;161A(1):59-69. doi: 10.1002/ajmg.a.35680. Epub 2012 Dec 13. Am J Med Genet A. 2013. PMID: 23239591 Free PMC article.
-
Distribution and frequency of intranuclear inclusions in female CGG KI mice modeling the fragile X premutation.Brain Res. 2012 Sep 7;1472:124-37. doi: 10.1016/j.brainres.2012.06.052. Epub 2012 Jul 11. Brain Res. 2012. PMID: 22796595 Free PMC article.
References
-
- Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease. Neurobiol Aging. 1997;18:S1–2. - PubMed
-
- Adams JS, Adams PE, Nguyen D, Brunberg JA, Tassone F, Zhang W, Koldewyn K, Rivera SM, Grigsby J, Zhang L, DeCarli C, Hagerman PJ, Hagerman RJ. Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS) Neurology. 2007;69:851–859. - PubMed
-
- Adams PE, Adams JS, Nguyen DV, Hessl D, Brunberg JA, Tassone F, Zhang W, Koldewyn K, Rivera SM, Grigsby J, Zhang L, Decarli C, Hagerman PJ, Hagerman RJ. Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers. Am J Med Genet B Neuropsychiatr Genet. 2010;153B:775–785. - PMC - PubMed
-
- Al-Hinti JT, Nagan N, Harik SI. Fragile X premutation in a woman with cognitive impairment, tremor, and history of premature ovarian failure. Alzheimer Dis Assoc Disord. 2007;21:262–264. - PubMed
-
- Allen EG, He W, Yadav-Shah M, Sherman SL. A study of the distributional characteristics of FMR1 transcript levels in 238 individuals. Hum Genet. 2004;114:439–447. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical